Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.43 |
| ▸ | KDR | P35968 | 3/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3121307 | 0.89 | EGFR (0.44) | EGFRPDGFRBKDRPDE10AKDM4E | |
| SCHEMBL92760 | 0.84 | EGFR (0.58) | EGFRPDGFRBKDRPDE10A | |
| SCHEMBL3112893 | 0.83 | KMT2A (0.42) | EGFRPDGFRBKDRPDE10ANPSR1 | |
| SCHEMBL3112917 | 0.82 | EGFR (0.50) | EGFRPDGFRBKDR | |
| Hydrochloric Acid SCHEMBL3107618 | 0.81 | EGFR (0.49) | EGFRPDGFRBKDR | |
| SCHEMBL3118952 | 0.81 | EGFR (0.49) | EGFRPDGFRBKDR | |
| Hydrochloric Acid SCHEMBL3113418 | 0.80 | EGFR (0.48) | EGFRPDGFRBKDR | |
| SCHEMBL3114572 | 0.76 | EGFR (0.45) | EGFRPDGFRBKDRPDE10AKDM4E | |
| SCHEMBL3113682 | 0.76 | KMT2A (0.42) | EGFRPDGFRBKDRPDE10ANPSR1 | |
| SCHEMBL3113664 | 0.75 | RPS6KA2 (0.46) | EGFRPDGFRBKDRPDE10ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130029942-A1 | COMPOUNDS AND THERAPEUTICAL USES THEREOF | MYREXIS, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| US-8309562-B2 | Compounds and therapeutical use thereof | MYREXIS, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| EP-2166589-A1 | ORGANIC EL DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2166592-A1 | ORGANIC EL DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2166590-A1 | ORGANIC EL ELEMENT AND ORGANIC EL MATERIAL-CONTAINING SOLUTION | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2166591-A1 | ORGANIC EL DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-24 | — | — | EP | disclosed |
| US-20100069383-A1 | COMPOUNDS AND THERAPEUTICAL USE THEREOF | Myriad Pharmaceuticals, Incorporated (US) | 2010-03-18 | — | — | US | disclosed |
| EP-2133932-A1 | ORGANIC EL DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
| EP-1572832-A1 | ELECTROLUMINESCENT DEVICE | Koninklijke Philips Electronics N.V. (NL) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004055129-A1 | ELECTROLUMINESCENT DEVICE | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2004-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029942-A1 | COMPOUNDS AND THERAPEUTICAL USES THEREOF | BAD, CASP3, BAX | EGFR 3147/4885PDGFRB 2783/4885KDR 3722/4885 |
| US-20100069383-A1 | COMPOUNDS AND THERAPEUTICAL USE THEREOF | BAD, CASP3, BAX | EGFR 2648/4885PDGFRB 2627/4885KDR 3809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.